MRUS – Merus N.V

Float Short %

6.41

Margin Of Safety %

Put/Call OI Ratio

0.65

EPS Next Q Diff

0.99

EPS Last/This Y

-2.44

EPS This/Next Y

1.23

Price

69.62

Target Price

92.75

Analyst Recom

Performance Q

25.62

Relative Volume

1.88

Beta

1.2

Ticker: MRUS

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	MRUS	67.27	0.72	0.17	23711
2025-08-18	MRUS	65.96	0.63	0.29	20660
2025-08-19	MRUS	63.35	0.63	0.33	20781
2025-08-20	MRUS	64.45	0.63	0.31	20822
2025-08-21	MRUS	66.67	0.63	0.66	20838
2025-08-22	MRUS	67.46	0.63	0.03	20860
2025-08-25	MRUS	66.1	0.63	0.17	20870
2025-08-26	MRUS	66.85	0.62	0.38	20932
2025-08-27	MRUS	67.23	0.63	0.01	20971
2025-08-28	MRUS	66.15	0.62	0.05	21121
2025-08-29	MRUS	65.76	0.64	150.20	20862
2025-09-02	MRUS	66.34	0.61	0.00	20467
2025-09-03	MRUS	66.61	0.60	0.00	20506
2025-09-04	MRUS	66.17	0.60	0.46	20620
2025-09-05	MRUS	67.11	0.61	0.14	21246
2025-09-08	MRUS	67.2	0.61	0.77	21120
2025-09-09	MRUS	68.55	0.64	0.89	25859
2025-09-10	MRUS	67.13	0.66	0.03	28018
2025-09-11	MRUS	69.82	0.67	1.61	30266
2025-09-12	MRUS	69.26	0.65	0.08	28231
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	MRUS	67.25	8.8	-13.7	-6.00
2025-08-18	MRUS	65.96	8.8	-3.8	-6.00
2025-08-19	MRUS	63.65	8.8	3.2	-6.00
2025-08-20	MRUS	64.43	8.8	-17.1	-6.00
2025-08-21	MRUS	66.67	8.8	-26.5	-6.00
2025-08-22	MRUS	67.54	8.8	-17.5	-6.00
2025-08-25	MRUS	65.79	8.8	-1.2	-6.00
2025-08-26	MRUS	66.86	8.8	-19.0	-6.00
2025-08-28	MRUS	66.10	8.8	-4.4	-6.00
2025-08-29	MRUS	65.83	8.8	-10.1	-6.00
2025-09-02	MRUS	66.31	9.7	-14.8	-5.79
2025-09-03	MRUS	66.65	9.7	-21.5	-5.79
2025-09-04	MRUS	66.20	9.7	-16.5	-5.79
2025-09-05	MRUS	67.47	9.7	-27.3	-5.79
2025-09-08	MRUS	67.19	9.7	-17.5	-5.79
2025-09-09	MRUS	68.60	9.7	-28.2	-5.79
2025-09-10	MRUS	67.14	9.7	-10.5	-5.79
2025-09-11	MRUS	69.80	9.7	-36.3	-5.79
2025-09-12	MRUS	69.62	9.7	-18.2	-5.79
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	MRUS	-1.03	-0.80	6.97
2025-08-18	MRUS	-1.03	-0.06	6.96
2025-08-19	MRUS	-1.04	-0.06	6.96
2025-08-20	MRUS	-1.04	-0.06	6.96
2025-08-21	MRUS	-1.04	-0.06	6.96
2025-08-22	MRUS	-1.04	-0.06	6.88
2025-08-25	MRUS	-1.15	6.47	6.88
2025-08-26	MRUS	-1.15	6.47	6.88
2025-08-27	MRUS	-1.15	6.47	6.52
2025-08-28	MRUS	-1.15	6.47	6.52
2025-08-29	MRUS	-1.15	6.47	6.52
2025-09-02	MRUS	-1.15	6.42	6.52
2025-09-03	MRUS	-1.15	6.42	6.52
2025-09-04	MRUS	-1.15	6.42	6.52
2025-09-05	MRUS	-1.15	6.42	6.52
2025-09-08	MRUS	-1.15	6.40	6.53
2025-09-09	MRUS	-1.12	6.40	6.53
2025-09-10	MRUS	-1.12	6.40	6.53
2025-09-11	MRUS	-1.12	6.40	6.41
2025-09-12	MRUS	-1.12	6.40	6.41
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-2.23

Avg. EPS Est. Current Quarter

-1.32

Avg. EPS Est. Next Quarter

-1.24

Insider Transactions

-1.12

Institutional Transactions

6.4

Beta

1.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-0.6

Max Drawdown 5-Year %

-60.4

Target Price

92.75

P/E

Forward P/E

PEG

P/S

93.59

P/B

6.25

P/Free Cash Flow

EPS

-5.54

Average EPS Est. Cur. Y

-5.79

EPS Next Y. (Est.)

-4.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-685.64

Relative Volume

1.88

Return on Equity vs Sector %

-70.7

Return on Equity vs Industry %

-57.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.21

EBIT Estimation

-18.2

Merus N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 260

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes BIZENGRI for the treatment of patients with pancreatic adenocarcinoma or non-small cell lung cancer (NSCLC) and non Neuregulin 1. The company is also developing MCLA-158 for the treatment of solid tumors; MCLA-129 for the treatment of patients with lungs and other solid tumors; ONO-4685 to treat relapsed/refractory T cell lymphoma; and INCA33890 for advanced solid tumors. In addition, it has collaboration agreement with Eli Lilly and Company, Ono Pharmaceutical Co., Ltd., and Betta Pharmaceuticals Co. Ltd. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

stock quote shares MRUS – Merus N.V Stock Price stock today

news today MRUS – Merus N.V stock forecast ,stock prediction 2023 2024 2025

marketwatch MRUS – Merus N.V yahoo finance google finance

stock history MRUS – Merus N.V invest stock market

stock prices MRUS premarket after hours

ticker MRUS fair value insiders trading

QGEN – Qiagen N.V.

Float Short %

3.13

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.01

EPS Last/This Y

1.96

EPS This/Next Y

0.2

Price

45.29

Target Price

52.51

Analyst Recom

2.2

Performance Q

-4.45

Relative Volume

0.68

Beta

0.67

Ticker: QGEN

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	QGEN	49.35	0.19	0.01	6783
2025-08-18	QGEN	48.65	0.15	0.00	4320
2025-08-19	QGEN	49.22	0.15	999.99	4349
2025-08-20	QGEN	49.2	0.15	0.01	4353
2025-08-21	QGEN	49.13	0.14	0.33	4622
2025-08-22	QGEN	49.76	0.14	1.00	4631
2025-08-25	QGEN	48.9	0.14	0.76	4673
2025-08-26	QGEN	48.85	0.16	0.02	5041
2025-08-27	QGEN	48.01	0.16	1.00	5047
2025-08-28	QGEN	46.14	0.16	0.04	5046
2025-08-29	QGEN	46.77	0.10	0.00	7552
2025-09-02	QGEN	46.94	0.10	0.00	7517
2025-09-03	QGEN	46.7	0.10	58.67	7821
2025-09-04	QGEN	47.04	0.15	1.00	8173
2025-09-05	QGEN	47.55	0.15	1.00	8173
2025-09-08	QGEN	47.58	0.15	1.00	8173
2025-09-09	QGEN	47.04	0.15	4.00	8172
2025-09-10	QGEN	46.01	0.16	999.99	8237
2025-09-11	QGEN	46.07	0.16	3.67	8238
2025-09-12	QGEN	45.28	0.15	30.50	8238
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	QGEN	49.35	0.0	98.6	2.35
2025-08-18	QGEN	48.63	0.0	85.2	2.35
2025-08-19	QGEN	49.19	0.0	100.5	2.35
2025-08-20	QGEN	49.21	0.0	94.2	2.35
2025-08-21	QGEN	49.13	0.0	93.1	2.35
2025-08-22	QGEN	49.75	0.0	101.4	2.35
2025-08-25	QGEN	48.90	0.0	83.9	2.35
2025-08-26	QGEN	48.86	0.0	93.4	2.35
2025-08-27	QGEN	48.00	0.0	83.5	2.35
2025-08-28	QGEN	46.14	0.0	71.1	2.35
2025-08-29	QGEN	46.53	0.0	98.9	2.35
2025-09-02	QGEN	46.92	0.0	99.2	2.35
2025-09-03	QGEN	46.74	0.0	163.6	2.35
2025-09-04	QGEN	47.03	0.0	170.7	2.35
2025-09-05	QGEN	47.55	0.0	173.2	2.36
2025-09-08	QGEN	47.58	0.0	166.5	2.36
2025-09-09	QGEN	47.04	0.0	158.7	2.36
2025-09-10	QGEN	45.99	0.0	151.3	2.36
2025-09-11	QGEN	46.06	0.0	166.8	2.36
2025-09-12	QGEN	45.29	0.0	155.1	2.36
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	QGEN	0.00	-0.19	3.07
2025-08-18	QGEN	0.00	2.77	3.07
2025-08-19	QGEN	0.00	2.77	3.07
2025-08-20	QGEN	0.00	2.77	3.07
2025-08-21	QGEN	0.00	2.77	3.07
2025-08-22	QGEN	0.00	2.77	3.07
2025-08-25	QGEN	0.00	1.04	3.07
2025-08-26	QGEN	0.00	1.04	3.07
2025-08-27	QGEN	0.00	1.04	2.85
2025-08-28	QGEN	0.00	1.04	2.85
2025-08-29	QGEN	0.00	1.04	2.85
2025-09-02	QGEN	0.00	0.59	2.85
2025-09-03	QGEN	0.00	0.59	2.85
2025-09-04	QGEN	0.00	0.59	2.85
2025-09-05	QGEN	0.00	0.59	2.85
2025-09-08	QGEN	0.00	0.37	2.85
2025-09-09	QGEN	0.00	0.37	2.85
2025-09-10	QGEN	0.00	0.37	2.85
2025-09-11	QGEN	0.00	0.37	3.13
2025-09-12	QGEN	0.00	0.37	3.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.6

Avg. EPS Est. Current Quarter

0.59

Avg. EPS Est. Next Quarter

0.61

Insider Transactions

Institutional Transactions

0.37

Beta

0.67

Average Sales Estimate Current Quarter

525

Average Sales Estimate Next Quarter

540

Fair Value

57.78

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

27.6

Max Drawdown 5-Year %

-37.4

Target Price

52.51

P/E

26.5

Forward P/E

17.88

PEG

3.67

P/S

4.81

P/B

2.8

P/Free Cash Flow

19.67

EPS

1.71

Average EPS Est. Cur. Y

2.36

EPS Next Y. (Est.)

2.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.3

Relative Volume

0.68

Return on Equity vs Sector %

-14.2

Return on Equity vs Industry %

-0.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

155.1

Qiagen N.V.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 5700

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

stock quote shares QGEN – Qiagen N.V. Stock Price stock today

news today QGEN – Qiagen N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch QGEN – Qiagen N.V. yahoo finance google finance

stock history QGEN – Qiagen N.V. invest stock market

stock prices QGEN premarket after hours

ticker QGEN fair value insiders trading

ARGX – argenx SE

Float Short %

2.95

Margin Of Safety %

-24

Put/Call OI Ratio

0.44

EPS Next Q Diff

0.86

EPS Last/This Y

EPS This/Next Y

7.51

Price

756.39

Target Price

821.14

Analyst Recom

1.33

Performance Q

28.91

Relative Volume

0.8

Beta

0.47

Ticker: ARGX

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	ARGX	653.97	0.41	0.25	13384
2025-08-18	ARGX	661.14	0.34	0.05	7956
2025-08-19	ARGX	657.12	0.32	2.31	8456
2025-08-20	ARGX	660.9	0.32	0.00	8494
2025-08-21	ARGX	663.79	0.31	0.52	8688
2025-08-22	ARGX	660.23	0.32	0.02	8744
2025-08-25	ARGX	677.69	0.30	0.29	9036
2025-08-26	ARGX	708.73	0.31	0.22	9564
2025-08-27	ARGX	708.07	0.31	0.39	9753
2025-08-28	ARGX	705.2	0.36	0.30	10156
2025-08-29	ARGX	712.28	0.38	0.12	10433
2025-09-02	ARGX	705.69	0.37	0.43	10643
2025-09-03	ARGX	722.78	0.37	0.21	10463
2025-09-04	ARGX	733.66	0.37	0.34	10463
2025-09-05	ARGX	750.86	0.36	0.98	10791
2025-09-08	ARGX	767.94	0.37	3.57	10869
2025-09-09	ARGX	767.74	0.41	0.62	11259
2025-09-10	ARGX	762.74	0.42	1.41	11323
2025-09-11	ARGX	763.84	0.43	0.70	11576
2025-09-12	ARGX	756.38	0.44	0.73	11624
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	ARGX	653.83	186.7	157.7	13.35
2025-08-18	ARGX	661.13	186.7	172.9	13.35
2025-08-19	ARGX	656.89	186.7	134.8	13.35
2025-08-20	ARGX	660.90	186.7	163.3	13.34
2025-08-21	ARGX	663.03	186.7	159.6	13.34
2025-08-22	ARGX	660.23	186.7	135.6	13.34
2025-08-25	ARGX	677.40	186.7	176.3	13.34
2025-08-26	ARGX	708.09	186.7	177.4	13.34
2025-08-27	ARGX	708.10	182.3	165.7	13.22
2025-08-28	ARGX	704.07	182.3	160.4	13.22
2025-08-29	ARGX	713.08	182.3	177.1	13.22
2025-09-02	ARGX	705.85	182.3	155.7	13.22
2025-09-03	ARGX	722.92	182.3	347.9	13.22
2025-09-04	ARGX	733.68	182.3	340.1	13.22
2025-09-05	ARGX	750.78	188.1	342.0	13.36
2025-09-08	ARGX	768.00	188.2	352.1	13.36
2025-09-09	ARGX	767.24	188.2	322.3	13.37
2025-09-10	ARGX	762.70	188.2	307.8	13.37
2025-09-11	ARGX	763.52	188.2	304.4	13.37
2025-09-12	ARGX	756.39	188.2	293.6	13.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	ARGX	0.00	-2.53	3.08
2025-08-18	ARGX	0.00	15.90	3.08
2025-08-19	ARGX	0.00	15.90	3.08
2025-08-20	ARGX	0.00	15.90	3.08
2025-08-21	ARGX	0.00	15.90	3.08
2025-08-22	ARGX	0.00	15.90	3.08
2025-08-25	ARGX	0.00	10.96	3.08
2025-08-26	ARGX	0.00	10.96	3.08
2025-08-27	ARGX	0.00	10.96	2.96
2025-08-28	ARGX	0.00	10.96	2.96
2025-08-29	ARGX	0.00	10.96	2.96
2025-09-02	ARGX	0.00	10.43	2.96
2025-09-03	ARGX	0.00	10.43	2.96
2025-09-04	ARGX	0.00	10.43	2.96
2025-09-05	ARGX	0.00	10.43	2.96
2025-09-08	ARGX	0.00	10.39	2.96
2025-09-09	ARGX	0.00	10.39	2.96
2025-09-10	ARGX	0.00	10.39	2.96
2025-09-11	ARGX	0.00	10.39	2.95
2025-09-12	ARGX	0.00	10.39	2.95
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

3.74

Avg. EPS Est. Current Quarter

3.69

Avg. EPS Est. Next Quarter

4.6

Insider Transactions

Institutional Transactions

10.39

Beta

0.47

Average Sales Estimate Current Quarter

921

Average Sales Estimate Next Quarter

1011

Fair Value

572.12

Quality Score

100

Growth Score

Sentiment Score

Actual DrawDown %

2.9

Max Drawdown 5-Year %

-38.2

Target Price

821.14

P/E

38.45

Forward P/E

30.62

PEG

1.01

P/S

15.12

P/B

7.59

P/Free Cash Flow

86.29

EPS

19.67

Average EPS Est. Cur. Y

13.37

EPS Next Y. (Est.)

20.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

41.87

Relative Volume

0.8

Return on Equity vs Sector %

-13.8

Return on Equity vs Industry %

-0.7

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.03

EBIT Estimation

293.6

argenx SE

Sector: Healthcare

Industry: Biotechnology

Employees: 1599

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

stock quote shares ARGX – argenx SE Stock Price stock today

news today ARGX – argenx SE stock forecast ,stock prediction 2023 2024 2025

marketwatch ARGX – argenx SE yahoo finance google finance

stock history ARGX – argenx SE invest stock market

stock prices ARGX premarket after hours

ticker ARGX fair value insiders trading

STLA – Stellantis N.V.

Float Short %

2.73

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

EPS Last/This Y

-1.37

EPS This/Next Y

1.5

Price

9.32

Target Price

10.38

Analyst Recom

2.97

Performance Q

-7.91

Relative Volume

0.6

Beta

1.53

Ticker: STLA

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	STLA	9.8	0.56	0.85	464415
2025-08-18	STLA	9.69	0.57	0.69	424641
2025-08-19	STLA	9.95	0.57	0.23	426623
2025-08-20	STLA	9.77	0.58	0.91	428692
2025-08-21	STLA	9.64	0.58	1.27	429674
2025-08-22	STLA	10.12	0.58	0.47	431159
2025-08-25	STLA	9.93	0.52	0.72	403963
2025-08-26	STLA	9.83	0.52	0.97	404486
2025-08-27	STLA	9.52	0.52	0.14	405641
2025-08-28	STLA	9.64	0.51	4.73	409673
2025-08-29	STLA	9.64	0.51	0.84	408612
2025-09-02	STLA	9.42	0.53	13.06	396138
2025-09-03	STLA	9.14	0.60	0.49	415737
2025-09-04	STLA	9.07	0.59	0.45	417457
2025-09-05	STLA	9.09	0.59	0.25	419343
2025-09-08	STLA	8.95	0.59	0.39	419599
2025-09-09	STLA	8.92	0.58	0.43	424671
2025-09-10	STLA	8.76	0.58	0.36	426239
2025-09-11	STLA	9.55	0.58	0.44	427228
2025-09-12	STLA	9.33	0.58	1.06	428963
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	STLA	9.79	-	7659.0	0.80
2025-08-18	STLA	9.69	-	7638.9	0.80
2025-08-19	STLA	9.94	-	7689.6	0.80
2025-08-20	STLA	9.77	-	7598.4	0.80
2025-08-21	STLA	9.64	-	7607.5	0.80
2025-08-22	STLA	10.12	-	7729.9	0.80
2025-08-25	STLA	9.93	-	7614.1	0.80
2025-08-26	STLA	9.83	-	7612.2	0.80
2025-08-27	STLA	9.52	-	7588.1	0.80
2025-08-28	STLA	9.64	-	7670.7	0.80
2025-08-29	STLA	9.64	-	7646.1	0.80
2025-09-02	STLA	9.42	-	8166.8	0.80
2025-09-03	STLA	9.14	-	8940.1	0.80
2025-09-04	STLA	9.08	-	9003.7	0.80
2025-09-05	STLA	9.08	-	8993.3	0.80
2025-09-08	STLA	8.96	-	8940.9	0.80
2025-09-09	STLA	8.92	-	8975.1	0.80
2025-09-10	STLA	8.76	-	8923.8	0.80
2025-09-11	STLA	9.57	-	9244.0	0.80
2025-09-12	STLA	9.32	-	8908.3	0.80
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	STLA	0.00	-8.30	3.13
2025-08-18	STLA	0.00	-10.62	3.17
2025-08-19	STLA	0.00	-10.62	3.17
2025-08-20	STLA	0.00	-10.62	3.17
2025-08-21	STLA	0.00	-10.62	3.17
2025-08-22	STLA	0.00	-10.62	3.17
2025-08-25	STLA	0.00	-10.20	3.17
2025-08-26	STLA	0.00	-10.20	3.17
2025-08-27	STLA	0.00	-10.20	3.17
2025-08-28	STLA	0.00	-10.20	3.17
2025-08-29	STLA	0.00	-10.20	3.17
2025-09-02	STLA	0.00	-10.31	2.73
2025-09-03	STLA	0.00	-10.31	2.73
2025-09-04	STLA	0.00	-10.31	2.73
2025-09-05	STLA	0.00	-10.31	2.73
2025-09-08	STLA	0.00	-10.23	2.73
2025-09-09	STLA	0.00	-10.23	2.73
2025-09-10	STLA	0.00	-10.23	2.73
2025-09-11	STLA	0.00	-10.23	2.73
2025-09-12	STLA	0.00	-10.23	2.73
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-10.23

Beta

1.53

Average Sales Estimate Current Quarter

35959

Average Sales Estimate Next Quarter

41475

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

68.4

Max Drawdown 5-Year %

-68.8

Target Price

10.38

P/E

Forward P/E

4.87

PEG

P/S

0.17

P/B

0.31

P/Free Cash Flow

EPS

-0.91

Average EPS Est. Cur. Y

0.8

EPS Next Y. (Est.)

2.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1.64

Relative Volume

0.6

Return on Equity vs Sector %

-22.8

Return on Equity vs Industry %

-11.9

EPS 1 7Days Diff

-1.2

EPS 1 30Days Diff

-1.23

EBIT Estimation

8908.3

Stellantis N.V.

Sector: Consumer Cyclical

Industry: Auto Manufacturers

Employees: 248243

Stellantis N.V. engages in the design, engineering, manufacturing, distribution, and sale of automobiles and light commercial vehicles, engines, transmission systems, metallurgical products, mobility services, and production systems worldwide. It provides luxury and premium vehicles; global sport utility vehicles; American and European brand vehicles, as well as parts and accessories. The company also provides contract services; retail and dealer financing services; and leasing and rental services. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, DS, Dodge, FIAT, Jeep, Maserati, Ram, Opel, Lancia, Vauxhall, Peugeot, and Comau brand names through distributors and dealers. Stellantis N.V. was founded in 1899 and is based in Hoofddorp, the Netherlands.

stock quote shares STLA – Stellantis N.V. Stock Price stock today

news today STLA – Stellantis N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch STLA – Stellantis N.V. yahoo finance google finance

stock history STLA – Stellantis N.V. invest stock market

stock prices STLA premarket after hours

ticker STLA fair value insiders trading

PHG – Koninklijke Philips N.V.

Float Short %

0.26

Margin Of Safety %

Put/Call OI Ratio

1.49

EPS Next Q Diff

0.03

EPS Last/This Y

-0.05

EPS This/Next Y

0.25

Price

28.21

Target Price

30.71

Analyst Recom

2.18

Performance Q

19.39

Relative Volume

0.51

Beta

0.82

Ticker: PHG

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	PHG	27.48	0.83	9.90	31688
2025-08-18	PHG	27.46	1.56	2.10	22590
2025-08-19	PHG	27.58	1.57	1.05	22685
2025-08-20	PHG	27.77	1.57	2.01	22808
2025-08-21	PHG	27.43	1.56	2.30	22784
2025-08-22	PHG	28.33	1.56	13.94	22808
2025-08-25	PHG	27.59	1.63	2.49	23540
2025-08-26	PHG	27.8	1.63	7.45	23588
2025-08-27	PHG	27.69	1.63	0.63	23654
2025-08-28	PHG	27.56	1.63	1.34	23688
2025-08-29	PHG	27.59	1.63	5.36	23688
2025-09-02	PHG	27.06	1.64	7.71	23692
2025-09-03	PHG	27.15	1.64	115.00	23721
2025-09-04	PHG	27.74	1.64	9.95	23722
2025-09-05	PHG	27.93	1.65	0.18	23832
2025-09-08	PHG	27.86	1.51	7.20	24677
2025-09-09	PHG	28.14	1.51	0.54	24705
2025-09-10	PHG	28.28	1.51	0.22	24767
2025-09-11	PHG	28.62	1.51	0.22	24762
2025-09-12	PHG	28.21	1.49	2.71	24915
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	PHG	27.48	-	488.0	1.57
2025-08-18	PHG	27.46	-	479.4	1.57
2025-08-19	PHG	27.57	-	475.5	1.57
2025-08-20	PHG	27.77	-	478.2	1.57
2025-08-21	PHG	27.44	-	451.6	1.57
2025-08-22	PHG	28.33	-	506.3	1.57
2025-08-25	PHG	27.59	-	448.8	1.57
2025-08-26	PHG	27.81	-	473.0	1.57
2025-08-27	PHG	27.68	-	465.3	1.57
2025-08-28	PHG	27.58	-	466.3	1.57
2025-08-29	PHG	27.58	-	472.1	1.57
2025-09-02	PHG	27.05	-	448.2	1.57
2025-09-03	PHG	27.15	-	734.3	1.57
2025-09-04	PHG	27.74	-	763.6	1.57
2025-09-05	PHG	27.93	-	711.8	1.57
2025-09-08	PHG	27.86	-	706.6	1.57
2025-09-09	PHG	28.14	-	753.2	1.57
2025-09-10	PHG	28.27	-	739.8	1.57
2025-09-11	PHG	28.62	-	748.2	1.57
2025-09-12	PHG	28.21	-	706.2	1.57
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	PHG	0	-7.29	0.26
2025-08-18	PHG	0	-7.26	0.26
2025-08-19	PHG	0	-7.26	0.26
2025-08-20	PHG	0	-7.26	0.26
2025-08-21	PHG	0	-7.26	0.26
2025-08-22	PHG	0	-7.26	0.26
2025-08-25	PHG	0	-8.58	0.26
2025-08-26	PHG	0	-8.58	0.26
2025-08-27	PHG	0	-8.58	0.38
2025-08-28	PHG	0	-8.58	0.38
2025-08-29	PHG	0	-8.58	0.38
2025-09-02	PHG	0	-8.80	0.38
2025-09-03	PHG	0	-8.80	0.38
2025-09-04	PHG	0	-8.80	0.38
2025-09-05	PHG	0	-8.80	0.38
2025-09-08	PHG	0	-7.57	0.38
2025-09-09	PHG	0	-7.57	0.38
2025-09-10	PHG	0	-7.57	0.38
2025-09-11	PHG	0	-7.57	0.26
2025-09-12	PHG	0	-7.57	0.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.41

Avg. EPS Est. Current Quarter

0.32

Avg. EPS Est. Next Quarter

0.44

Insider Transactions

Institutional Transactions

-7.57

Beta

0.82

Average Sales Estimate Current Quarter

4337

Average Sales Estimate Next Quarter

5052

Fair Value

33.81

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

50.2

Max Drawdown 5-Year %

-79.7

Target Price

30.71

P/E

Forward P/E

16.07

PEG

P/S

1.38

P/B

2.2

P/Free Cash Flow

19.78

EPS

-0.82

Average EPS Est. Cur. Y

1.57

EPS Next Y. (Est.)

1.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.89

Relative Volume

0.51

Return on Equity vs Sector %

-23.3

Return on Equity vs Industry %

-17

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

706.2

Koninklijke Philips N.V. NY Reg

Sector: Healthcare

Industry: Medical Devices

Employees: 67263

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

stock quote shares PHG – Koninklijke Philips N.V. Stock Price stock today

news today PHG – Koninklijke Philips N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch PHG – Koninklijke Philips N.V. yahoo finance google finance

stock history PHG – Koninklijke Philips N.V. invest stock market

stock prices PHG premarket after hours

ticker PHG fair value insiders trading

ASML – ASML Holding N.V.

Float Short %

0.69

Margin Of Safety %

-16

Put/Call OI Ratio

1.1

EPS Next Q Diff

2.18

EPS Last/This Y

EPS This/Next Y

1.57

Price

813.87

Target Price

839.19

Analyst Recom

1.83

Performance Q

3.52

Relative Volume

0.58

Beta

1.83

Ticker: ASML

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	ASML	742.15	1.09	1.20	210685
2025-08-18	ASML	747.55	1.11	0.81	172278
2025-08-19	ASML	743.84	1.10	0.81	176349
2025-08-20	ASML	749.04	1.09	0.57	179626
2025-08-21	ASML	735.27	1.08	0.83	183347
2025-08-22	ASML	754.54	1.07	0.73	186284
2025-08-25	ASML	754.2	1.08	1.59	173933
2025-08-26	ASML	763.19	1.08	0.64	176466
2025-08-27	ASML	770.18	1.06	0.85	178363
2025-08-28	ASML	763.01	1.06	1.17	179696
2025-08-29	ASML	741.46	1.07	1.42	181627
2025-09-02	ASML	725.18	1.08	0.95	171655
2025-09-03	ASML	736.96	1.08	0.85	177995
2025-09-04	ASML	753.14	1.07	0.90	180735
2025-09-05	ASML	781.45	1.07	0.78	184661
2025-09-08	ASML	796.43	1.06	1.08	178928
2025-09-09	ASML	805.13	1.08	1.04	181875
2025-09-10	ASML	792.12	1.09	1.03	184579
2025-09-11	ASML	803.99	1.09	1.19	187544
2025-09-12	ASML	814.15	1.10	0.66	190265
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	ASML	742.15	1.0	-703.3	23.96
2025-08-18	ASML	747.55	1.0	-471.6	23.96
2025-08-19	ASML	743.61	1.1	-582.9	23.96
2025-08-20	ASML	749.14	1.1	-497.4	23.96
2025-08-21	ASML	735.28	1.1	-653.1	23.96
2025-08-22	ASML	754.95	1.1	-202.3	23.96
2025-08-25	ASML	754.61	1.1	-528.3	23.91
2025-08-26	ASML	763.20	1.1	-362.2	23.91
2025-08-27	ASML	770.05	1.1	-341.1	23.91
2025-08-28	ASML	763.46	1.1	-566.8	23.91
2025-08-29	ASML	742.14	1.1	-818.0	23.91
2025-09-02	ASML	725.88	1.1	-1242.3	23.91
2025-09-03	ASML	737.23	1.1	369.7	23.91
2025-09-04	ASML	753.24	1.1	459.5	23.91
2025-09-05	ASML	781.70	1.1	833.8	23.92
2025-09-08	ASML	796.25	1.1	846.8	23.92
2025-09-09	ASML	805.14	1.1	623.9	23.91
2025-09-10	ASML	792.98	1.1	318.3	23.91
2025-09-11	ASML	804.16	1.1	609.1	23.91
2025-09-12	ASML	813.87	1.1	583.9	23.91
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	ASML	0.00	-7.57	0.64
2025-08-18	ASML	0.00	-6.37	0.64
2025-08-19	ASML	0.00	-6.37	0.64
2025-08-20	ASML	0.00	-6.37	0.64
2025-08-21	ASML	0.00	-6.37	0.64
2025-08-22	ASML	0.00	-6.37	0.64
2025-08-25	ASML	0.00	-0.89	0.64
2025-08-26	ASML	0.00	-0.89	0.64
2025-08-27	ASML	0.00	-0.89	0.74
2025-08-28	ASML	0.00	-0.89	0.74
2025-08-29	ASML	0.00	-0.89	0.74
2025-09-02	ASML	0.00	-0.83	0.74
2025-09-03	ASML	0.00	-0.83	0.74
2025-09-04	ASML	0.00	-0.83	0.74
2025-09-05	ASML	0.00	-0.83	0.74
2025-09-08	ASML	0.00	-0.69	0.74
2025-09-09	ASML	0.00	-0.69	0.74
2025-09-10	ASML	0.00	-0.69	0.74
2025-09-11	ASML	0.00	-0.69	0.69
2025-09-12	ASML	0.00	-0.69	0.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

4.55

Avg. EPS Est. Current Quarter

5.34

Avg. EPS Est. Next Quarter

6.73

Insider Transactions

Institutional Transactions

-0.69

Beta

1.83

Average Sales Estimate Current Quarter

7731

Average Sales Estimate Next Quarter

9149

Fair Value

685.77

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

26.7

Max Drawdown 5-Year %

-56.9

Target Price

839.19

P/E

31.18

Forward P/E

27.82

PEG

1.51

P/S

9.16

P/B

15.48

P/Free Cash Flow

31.88

EPS

26.1

Average EPS Est. Cur. Y

23.91

EPS Next Y. (Est.)

25.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.27

Relative Volume

0.58

Return on Equity vs Sector %

3.9

Return on Equity vs Industry %

3.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

583.9

ASML Holding N.V. - New York Re

Sector: Technology

Industry: Semiconductor Equipment & Materials

Employees: 43193

ASML Holding N.V. provides lithography solutions for the development, production, marketing, sales, upgrading, and servicing of advanced semiconductor equipment systems. It offers lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography systems solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical metrology systems to assess the quality of patterns on the wafers; and HMI electron beam solutions to identify and analyze individual chip defects. Further, the company provides computational lithography solutions, and lithography systems and control software solutions; and refurbishes and upgrades lithography systems, as well as offers customer support and related services. Additionally, it offers hardware, software, and services to chipmakers to produce the patterns of integrated circuits. The company operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

stock quote shares ASML – ASML Holding N.V. Stock Price stock today

news today ASML – ASML Holding N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch ASML – ASML Holding N.V. yahoo finance google finance

stock history ASML – ASML Holding N.V. invest stock market

stock prices ASML premarket after hours

ticker ASML fair value insiders trading

No more stocks to show

MRUS – Merus N.V

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MRUS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

QGEN – Qiagen N.V.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: QGEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y